Results 331 to 340 of about 1,602,934 (395)

Biomarkers of Drug‐Induced Kidney Injury: Use in Clinical Trials and Recent Examples of Impact on Drug Development

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
This manuscript describes the scope of implementation and impact of a regulatory agency‐qualified panel of six urine biomarkers on drug development, the process for which was conducted and funded by the Critical Path Institute, the Foundation for the National Institutes of Health, and the United States Food and Drug Administration.
Tanja S. Zabka   +7 more
wiley   +1 more source

Cytotoxicity and virulence attributes of <i>Pseudomonas aeruginosa</i> isolates from case reports of patients with necrotizing pneumonia. [PDF]

open access: yesRespir Med Case Rep
Bolig TC   +13 more
europepmc   +1 more source

Lung ultrasound alterations six months after COVID-19 pneumonia: a descriptive study. [PDF]

open access: yesBMC Pulm Med
Navarro-Romero F   +4 more
europepmc   +1 more source

Differential diagnosis in patients with both features of pneumonia and pulmonary edema on chest computed tomography. [PDF]

open access: yesMedicine (Baltimore)
Lee HJ   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy